Switzerland-based Sophia Genetics SA (NASDAQ: SOPH), a healthcare tech company, is debuting on Wall Street Friday. Here is what you should know about the company.
Software-as-a-service digital commerce platform provider VTEX (NYSE:VTEX) priced 19 million shares at $19 per share in its initial public offering. The…
Eliem Therapeutics (NASDAQ: ELYM), a Phase 2a biotech developing therapies for neuronal excitability disorders, filed an IPO prospectus with the SEC to raise up to $80 million.
Its two lead candidates are ETX-810 and ETX-155.